Moreover, stimulation of breast cancer cells with paclitaxel enhances their exosome-releasing capacity [167], an effect observed even when breast cancer cells are insensitive to aromatase inhibitor therapy [168]. The gene discussed is CYP19A1; the disease is breast carcinoma.